1-MNA

DIETARY_SUPPLEMENT2 trials

Sponsors

Pharmena North America, Michal Chudzik

Conditions

Covid19Fatigue Syndrome, ChronicHyperlipidemia

Phase 1

Safety of a Hypolipidemic Agent in Healthy Normal Volunteers

CompletedNCT00685737

Pharmena North AmericaHyperlipidemia

Start: 2007-12-31End: 2008-06-30Updated: 2008-06-27

Unknown Phase

Use of 1-MNA to Improve Exercise Tolerance and Fatigue in Patients After COVID-19

CompletedNCT04961476

Michal ChudzikCovid19, Fatigue Syndrome, Chronic

Start: 2021-01-08End: 2021-03-05Updated: 2021-07-21